Ledger. Australian venture funding, tracked

COO, Renew Pharmaceuticals

Declan Cassells

Coverage

Stories naming Declan Cassells. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.

Series A $6m

Ferronova raises another $6 million to advance image-guided cancer surgery

Adelaide medtech Ferronova has banked another $6 million from returning backers to advance its surgical tracer for cancer, lifting Series A funding to $17.5 million; backer parent UltraGreen.ai floated in Singapore this month.

Also movefm.com.au

2 deals

Biotech Ferronova boosts Series A capital raise by $6m

Adelaide biotech Ferronova added $6 million to its Series A from prior backers, lifting the round's total to $17.5 million; backer Renew's parent Ultragreen.ai floated in Singapore this month.

Also ferronova.com.au·movefm.com.au·Biotech Dispatch·Startup Daily

2 deals

South Australian biotech startup Ferronova banks $11 million to tackle cancer treatment

Adelaide cancer-focused biotech Ferronova has secured fresh backing: an investor round led by Irish strategic partner Renew Pharmaceuticals plus a federal research grant, to speed clinical trials in stomach and brain cancers.

Also SmartCompany·SmartCompany·Startup Daily·Business News Australia·Startup Daily

2 deals

Ferronova secures A$11 million to advance nanotech image-guided cancer therapy

Adelaide biotech Ferronova announced an A$11 million package: an A$8 million round led by Ireland's Renew Pharmaceuticals plus an A$3 million government CRC-P grant, with existing shareholders Uniseed and Artesian also participating.

Something wrong? Tell us